☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Glucagon
Eli Lilly's Baqsimi (glucagon 3mg) Nasal Powder Receives FDA's Approval for the Treatment of Severe Hypoglycemia
July 25, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.